3 terminated. 3 Phase 1, 1 Phase 2.
By phase and status
Follow Thymoma: new trials by email Literature Review of Thymoma trials Research Report on Thymoma
Trials (filtered) newest first · largest first
All 3 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Allogeneic Tumor Cell Vaccine (K562), Celecoxib, cyclophosphamide - Lung Cancer, Esophageal Cancer | Phase 1 | Terminated | 10 | 2010-12-07 | 2020-03-03 |
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Celebrex, Tumor cell vaccine - Mesolthelioma, Esophageal Cancer | Phase 1 | Terminated | 44 | 2010-12-01 | 2019-12-03 |
A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
PXD101with cisplatin+doxorubicin+cyclophosphamide - Thymoma, Thymic Carcinoma | Phase 1 / Phase 2 | Terminated | 26 | 2010-03-04 | 2017-08-10 |
Narrower conditions
Esophageal Neoplasms (2) · Lung Neoplasms (2) · Mesothelioma (1) · Mesothelioma, Malignant (1) · Sarcoma (1) · Thymus Neoplasms (1)
Broader conditions
Hemic and Lymphatic Diseases (3) · Lymphatic Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Complex and Mixed (3) · Thoracic Neoplasms (3) · Adenoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Esophageal Diseases (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Lung Diseases (2)
Interventions
Celecoxib (2) · Cyclophosphamide (1) · FANG vaccine (1)
Sponsors
National Cancer Institute (NCI) (3)
Countries
United States (3)
Top investigators
David S Schrump, M.D. (2) · Arun Rajan, M.D. (1)
Results publications
PMID 21502553, PMID 25189481